£5m Imperial-led lab will pioneer new approach to medicines manufacturing

A new collaboration between Imperial, UCL, and global pharmaceutical company Eli Lilly and Company will seek to transform medicines manufacturing. Lilly has committed £5 million to fund research into the more efficient manufacture of medicines - which could ultimately result in better and cheaper treatments for patients. The money will be used to fund a virtual lab, led by Imperial, to apply Process Systems Engineering (PSE) methods to the pharmaceutical industry. PSE uses computer assisted methods and models to design, control and optimise processes. The approach has previously been used in the petrochemical, chemicals, and consumer goods industries. The Pharmaceutical Systems Engineering Lab (PharmaSEL) will fall under the remit of Imperial and UCL's Centre for Process Systems Engineering (CPSE) and will see academics from Imperial and UCL undertake research to improve the efficiency of medicines manufacturing. New methods.